UPenn Perelman School of Medicine: Dual-target CAR T Cell Therapy Slows Growth of Aggressive Brain Cancer
June 03, 2025
June 03, 2025
PHILADELPHIA, Pennsylvania, June 3 (TNSjou) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
Dual-target CAR T cell therapy slows growth of aggressive brain cancer
Phase I clinical trial results demonstrate encouraging tumor reductions rarely seen in recurrent glioblastoma
A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and . . .
* * *
Dual-target CAR T cell therapy slows growth of aggressive brain cancer
Phase I clinical trial results demonstrate encouraging tumor reductions rarely seen in recurrent glioblastoma
A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and . . .